Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Regenerex Pharma (RGPX) Gains from Investment Securities (2013)

Regenerex Pharma (RGPX) reported Gains from Investment Securities of $0.0 for Q4 2013.

Regenerex Pharma (RGPX) has 1 years of Gains from Investment Securities data on file, last reported at $0.0 in Q4 2013.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to $0.0 in Q4 2013, while the trailing twelve-month figure through Nov 2013 was $0.0 (changed N/A YoY) and the FY2013 annual result came in at $0.0, changed N/A from the prior year.
  • Gains from Investment Securities was little changed at $0.0 in Q4 2013 per RGPX's latest filing.
  • Across five years, Gains from Investment Securities topped out at $0.0 in Q4 2013 and bottomed at $0.0 in Q4 2013.

Historic Data

Download Data 🔒
DateValue
Nov 30, 2013 0.00
Nov 30, 2013 0.00